stockportfolio.pro
Doximity, Inc. (DOCS)
Healthcare · Health Information Services · NYSE
Doximity, Inc. revenue & earnings — last 7 fiscal years
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | $116.39M | $206.90M | $343.55M | $419.05M | $475.42M | $570.40M | $644.86M |
| Gross profit | $101.49M | $175.70M | $303.76M | $365.56M | $424.75M | $514.52M | $574.54M |
| Net income | $29.74M | $50.21M | $154.78M | $112.82M | $147.58M | $223.19M | $196.05M |
| Net margin | 25.5% | 24.3% | 45.1% | 26.9% | 31.0% | 39.1% | 30.4% |
Source: Doximity, Inc. SEC filings (10-K).
What growth is priced into DOCS stock?
At today's market cap of $3.69B, Doximity, Inc. is priced for free-cash-flow growth of about -0.1% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $326.46M from the FY ending 2026-03-31). For comparison, free cash flow actually grew 31.6%/yr over the last five fiscal years and revenue 25.5%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 7 years of Doximity, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track DOCS in your portfolio →
Doximity, Inc. financial history by metric
About Doximity, Inc.
Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Doximity, Inc. — frequently asked questions
What is Doximity, Inc.'s revenue?
Doximity, Inc. (DOCS) reported revenue of $644.86M for fiscal year 2026, up 13.1% from the prior year, according to its SEC filings.
Is Doximity, Inc. profitable?
Yes. DOCS earned net income of $196.05M in fiscal 2026, a net margin of 30.4%.
What is DOCS's P/E ratio?
Doximity, Inc. trades at a price-to-earnings ratio of about 20.6 based on the latest data in our nightly-refreshed cache.
How fast is Doximity, Inc. growing?
DOCS's revenue grew at roughly 25.5% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Doximity, Inc. have?
As of fiscal year 2026, DOCS carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Doximity, Inc.'s gross margin?
DOCS's gross margin was 89.1% in fiscal 2026 — gross profit of $574.54M on revenue of $644.86M.
What is Doximity, Inc.'s market cap?
Doximity, Inc. (DOCS) has a market capitalization of about $3.69B, based on the latest data in our nightly-refreshed cache.
When does Doximity, Inc.'s fiscal year end?
DOCS's fiscal year ends in March. Its most recent annual filing covers the fiscal year ending 2026-03-31.
What growth is priced into DOCS stock?
At today's market cap of $3.69B, Doximity, Inc. is priced for free-cash-flow growth of about -0.1% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $326.46M from the FY ending 2026-03-31). For comparison, free cash flow actually grew 31.6%/yr over the last five fiscal years and revenue 25.5%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from Doximity, Inc.'s official SEC filings (10-K and 10-Q), covering 7 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.